Viva Biotech Revenues Surge On Move Into Contract Drug Manufacturing

nicolas_/E+ via Getty Images
Two key acquisitions last fall helped fuel fivefold rise in first-half revenue, as company swung back into profitability
A couple of recent acquisitions are proving strong tonic for Viva Biotech Holdings (OTCPK:VBIZF)(1873.HK),…

Click here to view the original article.